Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/18/2010WO2010030833A1 Method for controlling plant disease
03/18/2010WO2010030815A1 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
03/18/2010WO2010030811A2 CARBACEPHEM β-LACTAM ANTIBIOTICS
03/18/2010WO2010030810A1 Carbacephem beta-lactam antibiotics
03/18/2010WO2010030808A2 Novel antibiotics against resistant bacteria
03/18/2010WO2010030787A1 Estrogen receptor ligands
03/18/2010WO2010030783A1 Methods for the administration of iloperidone
03/18/2010WO2010030781A2 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer
03/18/2010WO2010030757A2 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/18/2010WO2010030755A1 Methods of using sustained release aminopyridine compositions
03/18/2010WO2010030735A2 Stabilized coating for pharmaceutical formulations
03/18/2010WO2010030727A1 3-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
03/18/2010WO2010030725A1 Compositions comprising polymers having amino sugar units and methods of making and using same
03/18/2010WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/18/2010WO2010030704A2 Antibacterial aminoglycoside analogs
03/18/2010WO2010030690A1 Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs
03/18/2010WO2010030607A1 Treatment of pervasive developmental disorders with redox-active therapeutics
03/18/2010WO2010030598A2 Pharmaceutical formulations comprising pemetrexed
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010030582A2 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition
03/18/2010WO2010030538A2 Compounds for the treatment of hepatitis c
03/18/2010WO2010030500A1 Aza-benzimidazolone chymase inhibitors
03/18/2010WO2010030470A1 Agmatine containing dietary supplements, nutraceuticals, and foods
03/18/2010WO2010030395A2 Withaferin a analogs and uses thereof
03/18/2010WO2010030360A1 3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
03/18/2010WO2010030325A1 Methods for increasing efficacy of radioimmunotherapy of melanoma
03/18/2010WO2010030244A1 A heparan sulphate which binds bmp2
03/18/2010WO2010030241A1 Therapeutic bone growth and regeneration
03/18/2010WO2010030132A2 Purification method for adefovir dipivoxil
03/18/2010WO2010030054A2 Uses of sesquiterpene derivatives
03/18/2010WO2010030027A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
03/18/2010WO2010030012A1 ESTERIFIED α-GALACTOSYLCERAMIDE
03/18/2010WO2010029998A1 Method for producing a monobenzyl ether of glycerol and/or a glycerol polymer, method for preventing yellowing, yellowing prevention agent, and buccal composition
03/18/2010WO2010029996A1 Pharmaceutical composition
03/18/2010WO2010029995A1 Therapeutic agent for pain
03/18/2010WO2010029986A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/18/2010WO2010029958A1 Novel pharmaceutical composition for treatment of nociceptive pain
03/18/2010WO2010029951A1 Orally administrable formulation containing branched chain amino acid
03/18/2010WO2010029938A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4–fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same
03/18/2010WO2010029930A1 Stable pharmaceutical formulation with limited discoloration
03/18/2010WO2010029925A1 Novel prostaglandin i<sb>2</sb> derivative
03/18/2010WO2010029915A1 Method for producing a composition with a high content of sapogenin
03/18/2010WO2010029913A1 Mental vigor improver
03/18/2010WO2010029577A2 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010WO2010029575A2 Docetaxel lyophilized parentaral formulation for safe drug delivery system and process of making thereof
03/18/2010WO2010029571A2 Modified release ramipril compositions and uses thereof
03/18/2010WO2010029562A1 Bioactive composition for the treatment of the hiv/aids, method for manufacturing and using the same
03/18/2010WO2010029561A1 A process for preparation of rosuvastatin acetonide calcium
03/18/2010WO2010029537A1 Antinecrotic activity of alpha 1-antitrypsin
03/18/2010WO2010029461A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010WO2010029436A2 Novel solid state forms of ranolazine salts
03/18/2010WO2010029433A1 A polysaccharide capsule enclosing a fatty acid oil-containing emulsion
03/18/2010WO2010029378A2 Anti-protozoa compounds
03/18/2010WO2010029364A1 Compounds
03/18/2010WO2010029352A1 Treatment of fibrotic eye disorders using an mmp2 inhibitor
03/18/2010WO2010029350A1 Treatment of fibrotic eye disorders
03/18/2010WO2010029335A1 Method for delivering a pharmaceutical composition to patient in need thereof
03/18/2010WO2010029313A1 Antiinfective compounds
03/18/2010WO2010029307A1 Medical product
03/18/2010WO2010029303A1 Gene silencing
03/18/2010WO2010029302A2 Compounds for treating viral infections
03/18/2010WO2010029300A1 Bis aromatic compounds for use in the treatment of inflammation
03/18/2010WO2010029278A2 Isolation and identification of glycosaminoglycans
03/18/2010WO2010029232A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
03/18/2010WO2010029185A1 Oligosaccharide compounds for use in mobilising stem cells
03/18/2010WO2010029131A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
03/18/2010WO2010029119A1 Novel imidazolidine compounds as androgen receptor modulators
03/18/2010WO2010029104A2 Use of a pharmaceutical composition for the local treatment of infections, and medical product
03/18/2010WO2010029082A1 Organic compounds
03/18/2010WO2010029062A1 Novel polymorphic form of chdmapp, method of preparation thereof, and pharmaceutical composition comprising same
03/18/2010WO2010029048A1 1, 2, 5-thiadiazole derivatives useful as immune potentiators
03/18/2010WO2010029038A1 Controlled-release nimesulide composition
03/18/2010WO2010029037A1 Orally dispersible nimesulide composition
03/18/2010WO2010029021A1 Taurine or taurine-like substances for the prevention of brain oedema
03/18/2010WO2010029003A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029001A1 Triazole compounds, use thereof, and agents containing same
03/18/2010WO2010029000A1 Triazole compounds, the use thereof and preparations containing these compounds
03/18/2010WO2010028981A1 New benzimidazole derivatives
03/18/2010WO2010028862A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010WO2010028858A1 Use of cis-imidazolines, particularly nutlins, for treating chemo-resistant cancer diseases
03/18/2010WO2010028840A1 2-ethoxy benzoic acid derivative
03/18/2010WO2010028826A2 A method for the production of bioadhesive compact matrices that can be used either as such or for the prolonged release of active substances, and compact matrices thus obtained
03/18/2010WO2010028794A1 Retard tablets containing quetiapine
03/18/2010WO2010028781A1 8- and 6,8-substituted-2'-deoxyguanosines and uses thereof
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010WO2010028769A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
03/18/2010WO2010028761A1 2-heteroaryl-pyrrolo [3, 4-c]pyrrole derivatives and the use thereof as scd inhibitors
03/18/2010WO2010028655A1 Isoquinolinone derivatives as nk3 antagonists
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010028542A1 Pleuromutilin phosphate, its pharmaceutical composition, preparation method and uses thereof
03/18/2010WO2010028515A2 A pentoxifilin-based dermatological pharmaceutical composition, for topical application, in cream, gel, ointment, solution, emulsion, liposome and microcapsule form
03/18/2010WO2010028487A1 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents
03/18/2010WO2010028458A1 Prodrugs of isoxazolyl penicillins and uses thereof
03/18/2010WO2010028419A1 Prevention of psychotic disorders and/or treatment of psychotic symptoms
03/18/2010WO2010011811A3 3-(phenoxyphenylmethyl)pyrrolidine compounds
03/18/2010WO2010011093A3 Composition for the treatment of skin flaps, comprising curcumin as an active ingredient
03/18/2010WO2010010470A3 Methods of administering topical antifungal formulations for the treatment of fungal infections
03/18/2010WO2010010454A3 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2010008744A3 Antineoplastic combinations containing hki-272 and vinorelbine
1 ... 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 ... 7860